Pooled data analysis studies 305 and 301
•
This pooled analysis was requested by the EMA as
supplementary
information to the Study 301 filing in the EU
but it was not
considered in the development of the updated SmPC
•
The data were sought to determine the
relative benefit of eribulin
compared with control by HER2 and TNBC status
